You just read:

Genomic Health Presents Data Demonstrating Importance of Oncotype DX Breast Recurrence Score® Test in Predicting Outcomes Across Patient Populations at ESMO 2017

News provided by

Genomic Health, Inc.

Sep 11, 2017, 08:00 ET